Research Publications


Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

Bowtell, DD; Bohm, S; Ahmed, AA; Aspuria, PJ; Bast, RC, Jr; Beral, V; Berek, JS; Birrer, MJ; Blagden, S; Bookman, MA; Brenton, JD; Chiappinelli, KB; Martins, FC; Coukos, G; Drapkin, R; Edmondson, R; Fotopoulou, C; Gabra, H; Galon, J; Gourley, C; Heong, V; Huntsman, DG; Iwanicki, M; Karlan, BY; Kaye, A; Lengyel, E; Levine, DA; Lu, KH; McNeish, IA; Menon, U; Narod, SA; Nelson, BH; Nephew, KP; Pharoah, P; Powell, DJ, Jr; Ramos, P; Romero, IL; Scott, CL; Sood, AK; Stronach, EA; Balkwill, FR
Nat Rev Cancer
Journal Article
High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
Stem Cells and Cancer
Refer to copyright notice on published article.

Creation Date 2015-10-28 01:52:44 Last Modified 2015-10-28 01:56:41